Continuous release of gentamicin from gold nanocarriers

• Main Authors: Perni, Stefano (Contributor), Prokopovich, Polina (Contributor)
• Other Authors: Massachusetts Institute of Technology. Center for Biomedical Engineering (Contributor)
• Format: Article
• Language: English
• Published: Royal Society of Chemistry, 2015-04-23T17:46:19Z.
• Subjects: Article
• Online Access: Get fulltext

 Antibiotics are still the most effective agents used to fight bacterial infections. Antibiotics are quickly metabolised or excreted from the human body, thus they need to be frequently administered (a few times a day) and their half life is usually an important factor in the therapeutic choice. In order to render the administration less frequent, antibiotic release from a carrier can be employed. In this work we covalently bound gentamicin to gold nanoparticles capped with cysteine or glutathione as gold nanoparticles are biologically safe. The conjugates exhibited antimicrobial activity against both S. aureus and MRSA at concentrations as low as 0.1 mg NP per ml consistent with an antibiotic load of 1-2% w/w as determined through TGA. No antimicrobial activity was exhibited by the unconjugated nanoparticles. The release of gentamicin from the conjugates was monitor in buffer solutions at pH = 7 and the antibiotic concentration continued to increase over two days. This work demonstrates that gold nanoparticles can be employed as antibiotic carriers providing a continuous release of antibiotic over a few days. Glutathione appeared to be a better coupling agent than cysteine allowing a higher load of gentamicin resulting in lower inhibitory concentrations of the conjugates.